NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1910854691|ref|XP_036113159|]
View 

exostosin-like 1 [Molossus molossus]

Protein Classification

exostosin( domain architecture ID 10503393)

exostosin is a family 47 glycosyltransferase that is required for the biosynthesis of heparan-sulfate

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
Glyco_transf_64 pfam09258
Glycosyl transferase family 64 domain; Members of this family catalyze the transfer reaction ...
413-650 6.62e-114

Glycosyl transferase family 64 domain; Members of this family catalyze the transfer reaction of N-acetylglucosamine and N-acetylgalactosamine from the respective UDP-sugars to the non-reducing end of [glucuronic acid]beta 1-3[galactose]beta 1-O-naphthalenemethanol, an acceptor substrate analog of the natural common linker of various glycosylaminoglycans. They are also required for the biosynthesis of heparan-sulphate.


:

Pssm-ID: 430488  Cd Length: 241  Bit Score: 341.58  E-value: 6.62e-114
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 413 FSALIWVGAP-GQPPLKLIQAVAGSQHCAQILVLWSNDKPLPP--RWPETVVPLIVIKGHRKV-SDRFFPYSAISTDAIL 488
Cdd:pfam09258   1 FTAVINTYYSrIDLLLKLLQRYAGSPHLAKIIVLWNNPKPPPElsRWPGTGVPVTVIRQKRNSlNNRFLPYPEIETDAVL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 489 SLDAHSSLSTSEVDFAFAVWQSFPERMVGFVTWSHFWDEAQGGWGYTAERANEFSMVLTSAAFYHRYYHTLFTYSLSKAL 568
Cdd:pfam09258  81 SLDDDILLSTDEIDFAFRVWRSFPDRIVGFPPRSHFWDLSSGRWGYTSEWTNEYSMVLTGAAFYHRYYLYLYTHSLPKSL 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 569 RSLADDAPTCVDVLMNFLVASVTKLPPIKVPYGKGHQEGRPPlVPAGLGSEPAPQPLNQDCINQVAAGFGHMPLVSSRLR 648
Cdd:pfam09258 161 RTLVDETQNCEDILMNFLVANVTRKPPVKVTQRKQFKEGKNS-GKVGLSSRPGHFLQRSKCINKFAAVFGYMPLVYSQIR 239

                  ..
gi 1910854691 649 LD 650
Cdd:pfam09258 240 LD 241
Exostosin pfam03016
Exostosin family; The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on ...
108-329 1.32e-32

Exostosin family; The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on 8q24.1, EXT2 on 11p11-13, and EXT3 on 19p have been associated with the autosomal dominant disorder known as hereditary multiple exostoses (HME). This is the most common known skeletal dysplasia. The chromosomal locations of other EXT genes suggest association with other forms of neoplasia. EXT1 and EXT2 have both been shown to encode a heparan sulphate polymerase with both D-glucuronyl (GlcA) and N-acetyl-D-glucosaminoglycan (GlcNAC) transferase activities. The nature of the defect in heparan sulphate biosynthesis in HME is unclear.


:

Pssm-ID: 397245  Cd Length: 290  Bit Score: 127.54  E-value: 1.32e-32
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 108 TQLKILASIEGSR--YHTVSPTEA----------CLHVLSLDAPAGQCSLV---------PPEWNE--GQNHLVLRLHPA 164
Cdd:pfam03016  33 AEQFLLESILHSRieCRTSDPDEAdcffvpfyasLDASRHLLNSALTDLFRelldwlksqYPYWNRsgGRDHFIVSGHPA 112
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 165 scsWTFQL-------GQAMVA--EASPTVDAFRPGFDVALPLLPETHPfqggAPGQLQQHSPHPG-VALLALAEERGGWR 234
Cdd:pfam03016 113 ---WSFRRtapdvdwGRAMLLnlTVLFSEDQFRPGKDVALPYPTPFHP----DIGQWQDISPSNRrKTLLFFAGNRRRGY 185
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 235 TAGTNSS---ACPWDGHCDQNHGSEQTHPRAS----LPNAIFCLIP---GPGASHFLQALQAGCIPVLLSPHWELPFSEV 304
Cdd:pfam03016 186 SGKIRPLlleECKGNPDADICGGLQCTPGRDKymelLRSSRFCLQPpgdTPTSPRLFDALLAGCIPVIISDGWELPFADV 265
                         250       260
                  ....*....|....*....|....*
gi 1910854691 305 IDWTKAAIVADERLPLQVLAALQEM 329
Cdd:pfam03016 266 IDWRKFSVFVPENDIPELKSILRSL 290
 
Name Accession Description Interval E-value
Glyco_transf_64 pfam09258
Glycosyl transferase family 64 domain; Members of this family catalyze the transfer reaction ...
413-650 6.62e-114

Glycosyl transferase family 64 domain; Members of this family catalyze the transfer reaction of N-acetylglucosamine and N-acetylgalactosamine from the respective UDP-sugars to the non-reducing end of [glucuronic acid]beta 1-3[galactose]beta 1-O-naphthalenemethanol, an acceptor substrate analog of the natural common linker of various glycosylaminoglycans. They are also required for the biosynthesis of heparan-sulphate.


Pssm-ID: 430488  Cd Length: 241  Bit Score: 341.58  E-value: 6.62e-114
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 413 FSALIWVGAP-GQPPLKLIQAVAGSQHCAQILVLWSNDKPLPP--RWPETVVPLIVIKGHRKV-SDRFFPYSAISTDAIL 488
Cdd:pfam09258   1 FTAVINTYYSrIDLLLKLLQRYAGSPHLAKIIVLWNNPKPPPElsRWPGTGVPVTVIRQKRNSlNNRFLPYPEIETDAVL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 489 SLDAHSSLSTSEVDFAFAVWQSFPERMVGFVTWSHFWDEAQGGWGYTAERANEFSMVLTSAAFYHRYYHTLFTYSLSKAL 568
Cdd:pfam09258  81 SLDDDILLSTDEIDFAFRVWRSFPDRIVGFPPRSHFWDLSSGRWGYTSEWTNEYSMVLTGAAFYHRYYLYLYTHSLPKSL 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 569 RSLADDAPTCVDVLMNFLVASVTKLPPIKVPYGKGHQEGRPPlVPAGLGSEPAPQPLNQDCINQVAAGFGHMPLVSSRLR 648
Cdd:pfam09258 161 RTLVDETQNCEDILMNFLVANVTRKPPVKVTQRKQFKEGKNS-GKVGLSSRPGHFLQRSKCINKFAAVFGYMPLVYSQIR 239

                  ..
gi 1910854691 649 LD 650
Cdd:pfam09258 240 LD 241
Exostosin pfam03016
Exostosin family; The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on ...
108-329 1.32e-32

Exostosin family; The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on 8q24.1, EXT2 on 11p11-13, and EXT3 on 19p have been associated with the autosomal dominant disorder known as hereditary multiple exostoses (HME). This is the most common known skeletal dysplasia. The chromosomal locations of other EXT genes suggest association with other forms of neoplasia. EXT1 and EXT2 have both been shown to encode a heparan sulphate polymerase with both D-glucuronyl (GlcA) and N-acetyl-D-glucosaminoglycan (GlcNAC) transferase activities. The nature of the defect in heparan sulphate biosynthesis in HME is unclear.


Pssm-ID: 397245  Cd Length: 290  Bit Score: 127.54  E-value: 1.32e-32
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 108 TQLKILASIEGSR--YHTVSPTEA----------CLHVLSLDAPAGQCSLV---------PPEWNE--GQNHLVLRLHPA 164
Cdd:pfam03016  33 AEQFLLESILHSRieCRTSDPDEAdcffvpfyasLDASRHLLNSALTDLFRelldwlksqYPYWNRsgGRDHFIVSGHPA 112
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 165 scsWTFQL-------GQAMVA--EASPTVDAFRPGFDVALPLLPETHPfqggAPGQLQQHSPHPG-VALLALAEERGGWR 234
Cdd:pfam03016 113 ---WSFRRtapdvdwGRAMLLnlTVLFSEDQFRPGKDVALPYPTPFHP----DIGQWQDISPSNRrKTLLFFAGNRRRGY 185
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 235 TAGTNSS---ACPWDGHCDQNHGSEQTHPRAS----LPNAIFCLIP---GPGASHFLQALQAGCIPVLLSPHWELPFSEV 304
Cdd:pfam03016 186 SGKIRPLlleECKGNPDADICGGLQCTPGRDKymelLRSSRFCLQPpgdTPTSPRLFDALLAGCIPVIISDGWELPFADV 265
                         250       260
                  ....*....|....*....|....*
gi 1910854691 305 IDWTKAAIVADERLPLQVLAALQEM 329
Cdd:pfam03016 266 IDWRKFSVFVPENDIPELKSILRSL 290
 
Name Accession Description Interval E-value
Glyco_transf_64 pfam09258
Glycosyl transferase family 64 domain; Members of this family catalyze the transfer reaction ...
413-650 6.62e-114

Glycosyl transferase family 64 domain; Members of this family catalyze the transfer reaction of N-acetylglucosamine and N-acetylgalactosamine from the respective UDP-sugars to the non-reducing end of [glucuronic acid]beta 1-3[galactose]beta 1-O-naphthalenemethanol, an acceptor substrate analog of the natural common linker of various glycosylaminoglycans. They are also required for the biosynthesis of heparan-sulphate.


Pssm-ID: 430488  Cd Length: 241  Bit Score: 341.58  E-value: 6.62e-114
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 413 FSALIWVGAP-GQPPLKLIQAVAGSQHCAQILVLWSNDKPLPP--RWPETVVPLIVIKGHRKV-SDRFFPYSAISTDAIL 488
Cdd:pfam09258   1 FTAVINTYYSrIDLLLKLLQRYAGSPHLAKIIVLWNNPKPPPElsRWPGTGVPVTVIRQKRNSlNNRFLPYPEIETDAVL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 489 SLDAHSSLSTSEVDFAFAVWQSFPERMVGFVTWSHFWDEAQGGWGYTAERANEFSMVLTSAAFYHRYYHTLFTYSLSKAL 568
Cdd:pfam09258  81 SLDDDILLSTDEIDFAFRVWRSFPDRIVGFPPRSHFWDLSSGRWGYTSEWTNEYSMVLTGAAFYHRYYLYLYTHSLPKSL 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 569 RSLADDAPTCVDVLMNFLVASVTKLPPIKVPYGKGHQEGRPPlVPAGLGSEPAPQPLNQDCINQVAAGFGHMPLVSSRLR 648
Cdd:pfam09258 161 RTLVDETQNCEDILMNFLVANVTRKPPVKVTQRKQFKEGKNS-GKVGLSSRPGHFLQRSKCINKFAAVFGYMPLVYSQIR 239

                  ..
gi 1910854691 649 LD 650
Cdd:pfam09258 240 LD 241
Exostosin pfam03016
Exostosin family; The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on ...
108-329 1.32e-32

Exostosin family; The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on 8q24.1, EXT2 on 11p11-13, and EXT3 on 19p have been associated with the autosomal dominant disorder known as hereditary multiple exostoses (HME). This is the most common known skeletal dysplasia. The chromosomal locations of other EXT genes suggest association with other forms of neoplasia. EXT1 and EXT2 have both been shown to encode a heparan sulphate polymerase with both D-glucuronyl (GlcA) and N-acetyl-D-glucosaminoglycan (GlcNAC) transferase activities. The nature of the defect in heparan sulphate biosynthesis in HME is unclear.


Pssm-ID: 397245  Cd Length: 290  Bit Score: 127.54  E-value: 1.32e-32
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 108 TQLKILASIEGSR--YHTVSPTEA----------CLHVLSLDAPAGQCSLV---------PPEWNE--GQNHLVLRLHPA 164
Cdd:pfam03016  33 AEQFLLESILHSRieCRTSDPDEAdcffvpfyasLDASRHLLNSALTDLFRelldwlksqYPYWNRsgGRDHFIVSGHPA 112
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 165 scsWTFQL-------GQAMVA--EASPTVDAFRPGFDVALPLLPETHPfqggAPGQLQQHSPHPG-VALLALAEERGGWR 234
Cdd:pfam03016 113 ---WSFRRtapdvdwGRAMLLnlTVLFSEDQFRPGKDVALPYPTPFHP----DIGQWQDISPSNRrKTLLFFAGNRRRGY 185
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1910854691 235 TAGTNSS---ACPWDGHCDQNHGSEQTHPRAS----LPNAIFCLIP---GPGASHFLQALQAGCIPVLLSPHWELPFSEV 304
Cdd:pfam03016 186 SGKIRPLlleECKGNPDADICGGLQCTPGRDKymelLRSSRFCLQPpgdTPTSPRLFDALLAGCIPVIISDGWELPFADV 265
                         250       260
                  ....*....|....*....|....*
gi 1910854691 305 IDWTKAAIVADERLPLQVLAALQEM 329
Cdd:pfam03016 266 IDWRKFSVFVPENDIPELKSILRSL 290
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH